OrthoLogic/J&J's DePuy AcroMed
This article was originally published in The Gray Sheet
Executive Summary
Johnson & Johnson DePuy AcroMed subsidiary gains exclusive worldwide rights to sell OrthoLogic's SpinaLogic non-invasive lumbar stimulation device, which is used as an adjunctive treatment after lumbar spinal fusion to increase the probability of successful fusion. The ten-year agreement that began Aug. 18 is expected to advance SpinaLogic's presence in the domestic and international spinal market